{"id":307723,"date":"2025-10-16T09:41:15","date_gmt":"2025-10-16T09:41:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/307723\/"},"modified":"2025-10-16T09:41:15","modified_gmt":"2025-10-16T09:41:15","slug":"illuminas-constellation-tech-a-star-in-genedx-pilot","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/307723\/","title":{"rendered":"Illumina&#8217;s constellation tech a star in Genedx pilot"},"content":{"rendered":"<p>Genedx LLC partnered with Illumina Inc. to test whether Illumina&#8217;s constellation map read technology could shed light on hard-to-detect variants that appear in rare diseases. Constellation met or exceeded the ability of other sequencing methods to detect variants implicated in multiple disorders and worked across a range of sample types, a study presented at the American Society for Human Genetics (ASHG) Annual Meeting in Boston on Oct. 15 found.<\/p>\n<p><a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/85-bioworld-medtech\" target=\"_blank\" rel=\"noopener\">BioWorld MedTech<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/153-clinical\" target=\"_blank\" rel=\"noopener\">Clinical<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/254-neonatal-pediatrics\" target=\"_blank\" rel=\"noopener\">Neonatal\/pediatrics<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/325-diagnostics\" target=\"_blank\" rel=\"noopener\">Diagnostics<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/401-u-s\" target=\"_blank\" rel=\"noopener\">U.S.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Genedx LLC partnered with Illumina Inc. to test whether Illumina&#8217;s constellation map read technology could shed light on&hellip;\n","protected":false},"author":3,"featured_media":307724,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[155746,104234,8258,65488,155748,152937,815,8834,155747,110861,155750,46199,155749,159,1439,67,132,68],"class_list":{"0":"post-307723","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-bioworld-medtech","9":"tag-clinical","10":"tag-constellation","11":"tag-diagnostics","12":"tag-exome","13":"tag-genedx","14":"tag-genetics","15":"tag-genomics","16":"tag-illumina-inc","17":"tag-medtech","18":"tag-neonatal-pediatrics","19":"tag-newborn-screening","20":"tag-novaseq","21":"tag-science","22":"tag-u-s","23":"tag-united-states","24":"tag-unitedstates","25":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115383192075536917","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/307723","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=307723"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/307723\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/307724"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=307723"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=307723"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=307723"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}